Additional Support Program via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

Objective

Compare endocrine therapy (ET) adherence at 12 months in diverse women exposed to text message reminders (TMR)-only, telephone-based motivational interviewing counseling (MI)-only, or both (TMR+MI), versus usual care.

Protocol #

A191901

Trial Phase:

Phase III

Principal Investigator:

Thomson, Maria

Cancer Type
  • Breast
Study Site
  • Peninsula Cancer Institute
  • Stony Point
  • VCU Community Memorial Healthcenter
  • Virginia Cancer Institute
  • Virginia Commonwealth University

- Women with pathologically confirmed initial diagnosis of stage I-III, hormone receptor positive, HER2-neu negative invasive breast cancer within
18 months prior to registration
- Patients must have received cancer-directed surgery, and/or completed all other adjuvant therapy, except reconstruction
- Patients must have initiated an endocrine therapy drug within the 6 months prior to registration or have received a prescription with stated intent
to initiate within 6 weeks after registration
- Patients must have no history of cancer as follows: invasive or non-invasive breast cancer at any time, and/or no history of non-breast cancer
within the last 5 years, excluding non-melanoma skin cancer
- Age >/= 18 years

Get more detailed information at ClinicalTrials.gov

  • Enrollment Status 1
  • Age Group Adult
  • Protocol Type Health Services Research
  • Research Study Team Tyler Phillips
    Email Study Contact

Click "I'm Interested" to get started. If you have questions, call our study contact.

I'm Interested
Have a question? We're here to help.

Email us or call us with your request.

Send an Email ยป (804) 628-6430
Share: